title: Update to the PhRMA perspective on population and individual bioequivalence.
authors.affiliation: DuPont Pharmaceuticals, Stine-Haskell Research Center, Newark, Delaware, 19714, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Barrett
authors.forename: V
authors.initials: V
authors.lastname: Batra
authors.forename: A
authors.initials: A
authors.lastname: Chow
authors.forename: J
authors.initials: J
authors.lastname: Cook
authors.forename: A L
authors.initials: AL
authors.lastname: Gould
authors.forename: A H
authors.initials: AH
authors.lastname: Heller
authors.forename: M W
authors.initials: MW
authors.lastname: Lo
authors.forename: S D
authors.initials: SD
authors.lastname: Patterson
authors.forename: B P
authors.initials: BP
authors.lastname: Smith
authors.forename: J A
authors.initials: JA
authors.lastname: Stritar
authors.forename: J M
authors.initials: JM
authors.lastname: Vega
authors.forename: N
authors.initials: N
authors.lastname: Zariffa
mesh_terms: D002626:Chemistry, Pharmaceutical; D006801:Humans; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration